Hypromellose–A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery
E Mašková, K Kubová, BT Raimi-Abraham… - Journal of controlled …, 2020 - Elsevier
Hydroxypropylmethylcellulose (HPMC), also known as Hypromellose, is a traditional
pharmaceutical excipient widely exploited in oral sustained drug release matrix systems …
pharmaceutical excipient widely exploited in oral sustained drug release matrix systems …
Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities
The use of cellulosic polymers as efficient reducing, coating agents, and stabilizers in the
formulation of silver nanoparticles (AgNPs) with antioxidant and antibacterial activity was …
formulation of silver nanoparticles (AgNPs) with antioxidant and antibacterial activity was …
Silver nanoparticle-coated ethyl cellulose inhibits tumor necrosis factor-α of breast cancer cells
Introduction Cancer is one of the leading causes of death worldwide. In many cases, cancer
is related to the elevated expression of a significant cytokine known as tumor necrosis factor …
is related to the elevated expression of a significant cytokine known as tumor necrosis factor …
[Retracted] Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia
CK Senthilvel, K Karuppaiyan… - Evidence‐Based …, 2022 - Wiley Online Library
The goal of this study was to develop atorvastatin (ATN) calcium biloaded, ie, immediate
release (IR) and sustained release (SR) capsules that would promote the quick onset of …
release (IR) and sustained release (SR) capsules that would promote the quick onset of …
[PDF][PDF] Green synthesis of silver nanoparticles reduced with Trigonella foenum-graecum and their effect on tumor necrosis factor-α in MCF7 cells
OBJECTIVE: Silver nanoparticles (AgNPs) are known to exhibit anti-inflammatory and
anticancer activities. They have been reported to reduce the levels of tumor necrosis factor …
anticancer activities. They have been reported to reduce the levels of tumor necrosis factor …
Development and evaluation of raloxifene-hydrochloride-loaded supersaturatable SMEDDS containing an acidifier
JH Lee, HH Kim, YH Cho, TS Koo, GW Lee - Pharmaceutics, 2018 - mdpi.com
Raloxifene hydrochloride (RLH) was formulated into a pH-modified supersaturatable self-
microemulsifying drug delivery system (S-SMEDDS) to increase drug solubility and …
microemulsifying drug delivery system (S-SMEDDS) to increase drug solubility and …
[PDF][PDF] Green synthesized silver nanoparticles using the plant-based reducing agent Matricaria chamomilla induce cell death in colorectal cancer cells.
AAH Abdellatif, HA Mohammed… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: There is a need to treat cancer cells with safe and natural nanoparticles to
avoid the side effects of chemotherapeutic agents. Chamomile is considered a safe, natural …
avoid the side effects of chemotherapeutic agents. Chamomile is considered a safe, natural …
Formulation and characterisation of a combination captopril and hydrochlorothiazide microparticulate dosage form
MTR Chikukwa, RB Walker, SMM Khamanga - Pharmaceutics, 2020 - mdpi.com
Cardiovascular diseases such as hypertension and cardiac failure in South African children
and adolescents are effectively managed long term, using a combination treatment of …
and adolescents are effectively managed long term, using a combination treatment of …
[HTML][HTML] Formulation of risperidone in floating microparticles to alleviate its extrapyramidal side effects
HO Ammar, MM Ghorab, AA Mahmoud… - Future Journal of …, 2016 - Elsevier
Risperidone is effective in the treatment of positive as well as negative symptoms of
schizophrenia. But, there is a strong correlation between plasma levels of risperidone and its …
schizophrenia. But, there is a strong correlation between plasma levels of risperidone and its …
[PDF][PDF] Swellable mucoadhesive hydroxypropyl methylcellulose microparticles incorporating ibuprofen for the local treatment of inflammatory diseases in the oral cavity
DT Pham, TL Nguyen, DXT Nguyen… - Journal of Applied …, 2023 - japsonline.com
The pharmaceutical products for local oral/buccal cavity treatments are limited and
unsatisfactory. Herein, we developed and characterized the hydroxypropyl methylcellulose …
unsatisfactory. Herein, we developed and characterized the hydroxypropyl methylcellulose …